Distribution of Acute and Chronic Kidney Disease Across Clinical Phenotypes for Sepsis

被引:3
|
作者
Molinari, Luca [1 ,2 ,5 ]
Del Rio-Pertuz, Gaspar [2 ,4 ]
Priyanka, Priyanka [2 ]
Smith, Ali [1 ]
Maggiore, Joseph C. [3 ]
Kennedy, Jason [1 ]
Gomez, Hernando [1 ,2 ]
Seymour, Christopher W. [1 ]
Kellum, John A. [1 ,2 ]
机构
[1] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15260 USA
[2] Univ Pittsburgh, Ctr Crit Care Nephrol, Pittsburgh, PA USA
[3] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA USA
[4] Univ Minnesota, Div Cardiol, Dept Med, Minneapolis, MN USA
[5] Univ Piemonte Orientale, Dept Translat Med, Novara, Italy
基金
美国国家卫生研究院;
关键词
acute kidney disease; acute kidney injury; biomarkers; chronic kidney disease; endotypes; insulin-like growth factor binding protein 7; phenotypes; sepsis; septic shock; tissue inhibitor of metalloproteinases-2; CRITICALLY-ILL PATIENTS; ALKALINE-PHOSPHATASE; INJURY; RECOVERY; FAILURE; AKI;
D O I
10.1016/j.chest.2024.03.006
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BACKGROUND: Sepsis is the most common cause of acute kidney injury (AKI) in critically ill patients. Four phenotypes (alpha, beta , gamma , delta) for sepsis, which have different outcomes and responses to treatment, were described using routine clinical data in the electronic health record. RESEARCH QUESTION: Do the frequencies of AKI, acute kidney disease (AKD), chronic kidney disease (CKD), and AKI on CKD differ by sepsis phenotype? STUDY DESIGN AND METHODS: This was a secondary analysis of a randomized clinical trial of early resuscitation, including patients with septic shock at 31 sites. After excluding patients with end-stage kidney disease and missing data, we determined frequencies of the following clinical outcomes: AKI (defined fi ned within 24 h as Kidney Disease: Improving Global Outcomes stages 2 or 3 or stage 1 with tissue inhibitor of metalloproteinases-2 x insulin-like growth factor binding protein 7 value of > 2.0), CKD, and AKD (persistence of AKI at any stage on day 7 after enrollment) across four phenotypes. We performed multivariable logistic regression to assess the risk-adjusted association between development of AKI and AKD and phenotype. RESULTS: Among 1,090 eligible patients, 543 patients (50%) had AKI. Across phenotypes, the frequencies of AKI varied, being highest in the delta and beta phenotypes (78% and 71%, respectively) and the lowest in the alpha phenotype (26%; P < .001). AKD occurred most often in the delta phenotype (41%) and least often in the alpha phenotype (8%; P < .001). The highest frequencies of CKD and of AKI on CKD were found in the beta phenotype (53% and 38% respectively; P < .001 for both). In the multivariable logistic regression models (alpha phenotype as reference), delta phenotype showed the strongest association with AKI (OR, 12.33; 95% CI, 7.81-19.47; P < .001) and AKD (OR, 9.18; 95% CI, 5.44-15.51; P < .001). INTERPRETATION: The rates of AKI and AKD differed across clinical sepsis phenotypes and are more common among patients with phenotypes beta and delta. Phenotype beta showed a higher level of underlying CKD that predisposed patients to new AKI. The alpha and gamma phenotypes showed lower frequencies of AKI and less progression to AKD.
引用
收藏
页码:480 / 490
页数:11
相关论文
共 50 条
  • [21] Pregnancy across the spectrum of chronic kidney disease
    Hladunewich, Michelle A.
    Melamad, Nir
    Bramham, Kate
    KIDNEY INTERNATIONAL, 2016, 89 (05) : 995 - 1007
  • [22] CLINICAL PHENOTYPES OF POLYCYSTIC KIDNEY DISEASE IN EGYPTIAN CHILDREN
    Nabhan, Marwa M.
    Soliman, Neveen A.
    Bazaraa, Hafez M.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [23] Clinical Features and Outcomes of COVID-19 Patients with Acute Kidney Injury and Acute Kidney Injury on Chronic Kidney Disease
    Xu, Zhifeng
    Zhang, Yuanyuan
    Zhang, Chun
    Xiong, Fei
    Zhang, Jianduan
    Xiong, Jing
    AGING AND DISEASE, 2022, 13 (03): : 884 - 898
  • [24] Progression from Acute Kidney Injury to Chronic Kidney Disease: Clinical and Experimental Insights and Queries
    Zager, Richard A.
    NEPHRON CLINICAL PRACTICE, 2014, 127 (1-4): : 46 - 50
  • [25] Biomarkers in acute and chronic kidney disease
    Nickolas, Thomas L.
    Barasch, Jonathan
    Devarajan, Prasad
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2008, 17 (02): : 127 - 132
  • [26] Biomarkers of Acute and Chronic Kidney Disease
    Zhang, William R.
    Parikh, Chirag R.
    ANNUAL REVIEW OF PHYSIOLOGY, VOL 81, 2019, 81 : 309 - 333
  • [27] Chronic kidney disease worsens sepsis and sepsis-induced acute kidney injury by releasing High Mobility Group Box Protein-1
    Leelahavanichkul, Asada
    Huang, Yuning
    Hu, Xuzhen
    Zhou, Hua
    Tsuji, Takayuki
    Chen, Richard
    Kopp, Jeffrey B.
    Schnermann, Juergen
    Yuen, Peter S. T.
    Star, Robert A.
    KIDNEY INTERNATIONAL, 2011, 80 (11) : 1198 - 1211
  • [28] The Acute Kidney Injury to Chronic Kidney Disease Continuum
    Pannu, Neesh
    Hemmelgarn, Brenda
    ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (03) : 233 - 234
  • [29] Acute Kidney Injury: Gateway to Chronic Kidney Disease
    Heung, Michael
    Chawla, Lakhmir S.
    NEPHRON CLINICAL PRACTICE, 2014, 127 (1-4): : 30 - 34
  • [30] Acute Kidney Injury to Chronic Kidney Disease Transition
    Fiorentino, Marco
    Grandaliano, Giuseppe
    Gesualdo, Loreto
    Castellano, Giuseppe
    ACUTE KIDNEY INJURY - BASIC RESEARCH AND CLINICAL PRACTICE, 2018, 193 : 45 - 54